पीपल्स डेली की खबर के मुताबिक: ब्राजीलियाई न्यू क्राउन वैक्सीन स्वयंसेवक की मौत का कारण आत्महत्या है, many parties suggest to resume testing
The Brazilian news website “G1” said on the 10th that after the clinical test of Coronavac, बीजिंग केक्सिंग बायोलॉजिकल कंपनी द्वारा विकसित एक नया कोरोनोवायरस वैक्सीन।, लिमिटेड. और ब्राज़ीलियाई बुटानटन संस्थान, निलंबित किया गया था, the National Research and Ethics Committee under the Ministry of Health of Brazil and an independent international The investigation committee recommended that vaccine testing be resumed.
“G1” said that Brazil’s National Health Supervision Agency (Anvisa) urgently suspended the clinical testing of Kexing vaccine on the 9th, citing “serious adverse reactions.” The so-called adverse reaction is the unfortunate death of a volunteer who participated in the test. According to the latest police report, the deceased was a 32-year-old male resident of Sao Paulo. The cause of death was confirmed by forensic medicine as suicide.
On the 10th local time, Anvisa held a press conference saying that the decision to suspend vaccine testing was “technical.” Due to the attack on the government’s network, the data from the Butantin Institute was not received in time. The data received on the 9th was incomplete, so the decision to suspend the test had to be made.
The Buttantan Institute retorted that it had sent all the data to Anvisa. The director of the institute, Kovas, once again emphasized that the death has nothing to do with the vaccine itself, and the suspension of testing will cause unnecessary pain and anxiety. हालाँकि, based on the principles of ethics and confidentiality, no more details about the volunteer could be disclosed.
According to the Sao Paulo Page, the National Research and Ethics Committee under the Brazilian Ministry of Health stated on the 10th that the agency analyzed preliminary data on volunteer deaths and that “the cause of death has nothing to do with the vaccine” and suggested that there is no need to suspend testing of the vaccine in Brazil. An international independent investigation committee sent Anvisa data about the Coxing vaccine and recommended that Brazil resume testing of the vaccine. Anvisa said that this is being analyzed and evaluated, but has not yet made any latest decisions on the progress of vaccine research.
The Brazilian news website “Terra” stated that Brazilian President Bolsonaro “celebrated” the suspension of vaccine testing on a social platform on the 10th, saying this was another victory for him. Bolsonaro also said on the same day that Brazil must stop being a “sissy” country and “open its chest” to face the pandemic of the new crown virus. Cofri, director of the Brazilian Society of Immunology, said that politicizing the debate about vaccines would only invite misinformation.
death of new crown vaccine volunteer
(स्रोत: World Wide Web)
